Adhesion of hydroxyapatite crystals to anionic sites on the surface of renal epithelial cells

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 2 42-2, 1997, Pages

  Lieske, John C ^a   Norris, Rebbecca ^a   Toback, F Gary ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

BSC 1 cells; Glycosaminoglycan; Madin Darby canine kidney cells; Nephrolithiasis; Sialic acid

Indexed keywords

HYDROXYAPATITE; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL STRAIN 3T3; CONTROLLED STUDY; CRYSTAL; KIDNEY EPITHELIUM; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030769882     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.2.f224     Document Type: Article

References (49)

1. Angell, A. H., and M. I. Resnick. Surface interaction between glycosaminoglycans and calcium oxalate. J. Urol. 141: 1255-1258, 1989.
2. Berg, C., and H. G. Tiselius. The effects of citrate on hydroxyapatite-induced calcium oxalate crystallization and on the formation of calcium phosphate crystals. Urol. Res. 17: 167-172, 1989.
3. Borkowf, A., H. S. Cheung, and D. J. McCarty. Endocytosis is required for the mitogenic effect of basic calcium phosphate crystals in fibroblasts. Calcif. Tissue Int. 40: 173-176, 1987.
4. Burns, J. R., and B. Finlayson. A proposal for a standard reference artificial urine in in vitro urolithiasis experiments. Investig. Urol. (Berl.) 18: 167-169, 1980.
5. Cassidy, J. T., G. W. Jourdin, and S. Roseman. The sialic acids. VI. Purification and properties of sialidase from Clostridium perfringens. J. Biol. Chem. 240: 3501-3506, 1965.
6. Chambers, A., A. Hodgkinson, and G. Hornung. Electron probe analysis of small urinary tract calculi. Investig. Urol. (Berl.) 9: 376-384, 1972.
7. Cheung, H. S., and D. J. McCarty. Mitogenesis induced by calcium-containing crystals: role of intracellular dissolution. Exp. Cell Res. 157: 63-70, 1985.
8. Cheung, H. S., P. J. Mitchell, and W. J. Pledger. Induction of expressions of c-fos and c-myc protoncogenes by basic calcium phosphate crystal: effect of B-interferon. Cancer Res. 49: 134-138, 1989.
9. Cheung, H. S., J. D. Sallis, P. G. Mitchell, and J. A. Struve. Inhibition of basic calcium phosphate crystal-induced mitogenesis by phosphocitrate. Biochem. Biophys. Res. Commun. 171: 20-25, 1990.
10. Cheung, H. S., M. T. Story, and D. J. McCarty. Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum. 27: 668-674, 1984.
11. Fellstrom, B., U. Backman, B. Danielson, and B. Wikstrom. Treatment of renal stone disease with the synthetic glycosaminoglycan pentosan polysulphate. World J. Urol. 12: 52-54, 1994.
12. Finlayson, B., and S. Reid. The expectation of free and fixed particles in urinary stone disease. Investig. Urol. (Berl.) 15: 442-448, 1978.
13. Gohel, M. D., D. K. Y. Shum, and M. K. Li. The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine. Urol. Res. 20: 13-17, 1992.
14. Hess, B. Tamm-Horsfall glycoprotein: inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Urol. Res. 20: 83-86, 1992.
15. Hess, B., Y. Nakagawa, and F. L. Coe. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F99-F106, 1989.
16. Hunter, G. K., P. V. Hauschka, A. R. Poole, L. C. Rosenberg, and H. A. Goldberg. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 317: 59-64, 1996.
17. Johnson, C. M., D. M. Wilson, W. M. O'Fallon, R. S. Malek, and L. T. Kurland. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 16: 624-631, 1979.
18. Johnsson, M., C. F. Richardson, J. D. Sallis, and G. H. Nancollas. Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite. Calcif. Tissue Int. 49: 134-137, 1991.
19. Khan, S. R. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate. J. Urol. 157: 376-383, 1997.
20. Kok, D. J., and S. R. Khan. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 46: 847-854, 1994.
21. Kumar, S., and A. Muchmore. Tamm-Horsfall protein-uromodulin (1950-1990). Kidney Int. 37: 1395-1401, 1990.
22. Lieske, J. C., R. Leonard, H. Swift, and F. G. Toback. Fate of calcium oxalate monohydrate crystals in renal epithelial cells after internalization (Abstract). J. Am. Soc. Nephrol. 7: 1804, 1996.
23. Lieske, J. C., R. Leonard, H. S. Swift, and F. G. Toback. Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F192-F199, 1996.
24. Lieske, J. C., R. Leonard, and F. G. Toback. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F604-F612, 1995.
25. Lieske, J. C., H. S. Swift, T. Martin, B. Patterson, and F. G. Toback. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc. Natl. Acad. Sci. USA 91: 6987-6991, 1994.
26. Lieske, J. C., and F. G. Toback. Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis. Semin. Nephrol. 16: 458-473, 1996.
27. Lieske, J. C., F. G. Toback, and S. Deganello. Face-selective adhesion of calcium oxalate dihydrate crystals to renal epithelial cells. Calcif. Tissue Int. 58: 195-200, 1996.
28. Lieske, J. C., M. M. Walsh-Reitz, and F. G. Toback. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F622-F630, 1992.
29. Mandel, N. S., and G. S. Mandel. Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. J. Urol. 142: 1513-1515, 1989.
30. Mandel, N. S., and G. S. Mandel. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J. Urol. 142: 1516-1521, 1989.
31. Martin, X., P. G. Werness, J. H. Bergert, and L. H. Smith. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth. J. Urol. 132: 786-788, 1984.
32. Muench, K. A. Preparation of calcium phosphate gel. In: Procedures in Nucleic Acid Research, edited by G. L. Cantoni and D. R. Davies. New York: Harper and Row, 1971, p. 516-517.
33. Nakagawa, Y., V. Abram, F. J. Kezdy, E. T. Kaiser, and F. L. Coe. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J. Biol. Chem. 258: 12594-12600, 1983.
34. Parks, J. H., and F. L. Coe. Urine citrate and calcium in calcium nephrolithiasis. Adv. Exp. Med. Biol. 208: 445-449, 1986.
35. Praeger, F. C., and B. A. Gilcrest. Calcium, lanthanum, pyrophosphate, and hydroxyapatite: a comparative study in fibroblast mitogenicity. Proc. Soc. Exp. Biol. Med. 190: 28-34, 1989.
36. Prien, E. L. Studies on urolithiasis. III. Physicochemical principles in stone formation and prevention. J. Urol. 73: 627-652, 1955.
37. Prien, E. L. The riddle of Randall's plaques. J. Urol. 114: 500-507, 1975.
38. Riese, R. J., N. S. Mandel, J. H. Wiessner, G. S. Mandel, C. G. Becker, and J. G. Kleinman. Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F177-F184, 1992.
39. Riese, R. J., J. W. Riese, J. G. Kleinman, J. H. Wiessner, G. S. Mandel, and N. S. Mandel. Specificity in calcium oxalate adherence to papillary epithelial cells in culture. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F1025-F1032, 1988.
40. Shiraga, H., W. Min, W. J. Vandusen, M. D. Clayman, D. Miner, C. H. Terrell, J. R. Sherbotie, J. W. Foreman, C. Przysiecki, E. G. Neilson, and J. R. Hoyer. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc. Natl. Acad. Sci. USA 89: 426-430, 1992.
41. Shum, D. K. Y., and M. D. I. Gohel. Separate effect of urinary chondroitin sulfate and heparan sulfate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects. Clin. Sci. (Colch.) 85: 33-39, 1993.
42. Sierakowski, R., B. Finlayson, R. R. Landes, C. D. Finlayson, and N. Sierakowski. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Investig. Urol. (Berl.) 15: 438-441, 1978.
43. Smith, L. H., and P. G. Werness. Hydroxyapatite: the forgotten crystal in calcium urolithiasis. Trans. Am. Clin. Clem. Assoc. 95: 183-190, 1983.
44. Verkoelen, C. F., J. C. Romijn, L. C. Cao, E. R. Boevé, W. C. De Bruijn, and F. H. Schroder. Crystal-cell interaction inhibition by polysaccharides. J. Urol. 155: 749-752, 1996.
45. Verkoelen, C., J. C. Romijn, W. C. De Bruijn, E. R. Boevé, L.-C. Cao, and F. H. Schroder. Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney Int. 48: 129-138, 1995.
46. Werness, P. G., J. H. Bergert, and L. H. Smith. Crystalluria. J. Crystal Growth 53: 166-181, 1981.
47. Wilson, J. W. L., P. G. Werness, and L. H. Smith. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J. Urol. 134: 1255-1258, 1985.
48. Worcester, E. M., S. S. Blumenthal, A. M. Beshensky, and D. L. Lewand. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J. Bone Miner. Res. 7: 1029-1036, 1992.
49. Worcester, E. M., Y. Nakagawa, C. L. Wabner, S. Kumar, and F. L. Coe. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F1197-F1205, 1988.